Defibrillators Global Market Report 2026

Defibrillators are medical devices designed to deliver a controlled electrical shock to the heart to restore a normal cardiac rhythm during critical cardiac emergencies. They incorporate monitoring, sensing, and energy delivery technologies to assess cardiac activity and provide prompt therapeutic intervention when necessary. These devices play a vital role in emergency and critical care by enabling timely cardiac rhythm management and improving patient outcomes.

The primary product types of defibrillators include implantable cardioverter defibrillators, external defibrillators, wearable cardioverter defibrillators, and automated external defibrillators. Implantable cardioverter defibrillators refer to implantable medical devices that continuously monitor heart rhythm and automatically deliver electrical therapy to correct life-threatening cardiac arrhythmias. These devices utilize technologies such as biphasic waveform technology, monophasic waveform technology, and connected or smart Internet of Things systems and are distributed through direct sales and retail and electronic commerce channels. The various applications include ventricular tachycardia and ventricular fibrillation, sudden cardiac arrest, cardiac resynchronization therapy, atrial fibrillation, and bradycardia, and they are used by end users including hospitals and clinics, pre-hospital emergency care, public access market, home care settings, alternative care settings, and pre-hospital care systems.

Tariffs are influencing the defibrillators market by increasing the cost of imported medical components, electronic systems, batteries, and specialized manufacturing materials required for device production. These trade restrictions are affecting implantable cardioverter defibrillators, external defibrillators, and connected cardiac monitoring systems, particularly in regions dependent on imported medical device technologies such as North America, Europe, and Asia-Pacific. Component-intensive segments, including electronic circuitry, sensors, and smart connectivity modules, are experiencing higher production costs due to global supply chain dependencies. However, tariffs are also encouraging domestic medical device manufacturing, local supplier development, and investments in regional healthcare technology ecosystems.

The defibrillators market research report is one of a series of new reports from The Business Research Company that provides defibrillators market statistics, including defibrillators industry global market size, regional shares, competitors with a defibrillators market share, detailed defibrillators market segments, market trends and opportunities, and any further data you may need to thrive in the defibrillators industry. This defibrillators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The defibrillators market size has grown strongly in recent years. It will grow from $10.99 billion in 2025 to $11.81 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period was driven by increasing prevalence of cardiovascular diseases, rising demand for emergency cardiac care equipment, growing adoption of automated external defibrillators, increasing healthcare infrastructure development, and rising awareness about sudden cardiac arrest management.

The defibrillators market size is expected to see strong growth in the next few years. It will grow to $15.5 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth during the forecast period is attributed to increasing adoption of connected defibrillator technologies, growing demand for home-based cardiac care solutions, rising integration of AI-based cardiac monitoring, increasing healthcare digitization initiatives, and growing focus on advanced portable cardiac devices. Major trends in the forecast period include increasing development of advanced cardiac rhythm monitoring technologies, growing adoption of portable and wearable defibrillation devices, rising integration of real-time patient monitoring capabilities, increasing focus on improved defibrillator battery efficiency and performance, and growing demand for automated emergency cardiac care solutions.

The rising incidence of cardiovascular diseases is expected to drive the growth of the defibrillators market in the coming years. Cardiovascular diseases are disorders affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and stroke, and they continue to be one of the leading causes of death worldwide. The increasing incidence of cardiovascular diseases is primarily attributed to population aging, which has resulted in a larger number of individuals being at risk of heart disease and stroke. Defibrillators play a critical role in the treatment of cardiovascular diseases by providing rapid intervention for sudden cardiac arrest and severe cardiac rhythm disorders, thereby improving survival rates and reducing cardiovascular-related mortality. For instance, in August 2025, according to a report published by the National Center for Biotechnology Information (NCBI), a division of the US-based National Library of Medicine (NLM), the prevalence of cardiovascular disease is projected to increase by 90.0% between 2025 and 2050, with crude mortality expected to rise by 73.4% and crude disability-adjusted life years (DALYs) by 54.7%, while total deaths are forecast to increase from 20.5 million in 2025 to 35.6 million by 2050. Therefore, the rising incidence of cardiovascular diseases is driving the growth of the defibrillators market.

Major companies operating in the defibrillators market are concentrating on developing advanced products, such as extravascular implantable cardioverter defibrillator (EV-ICD) systems, to enhance arrhythmia management, minimize procedure-related complications, and improve patient quality of life. Extravascular implantable cardioverter defibrillator systems are advanced cardiac rhythm management devices that provide life-saving defibrillation and pacing therapies without positioning leads inside the heart or blood vessels, thereby reducing the risks associated with transvenous lead implantation. For instance, in March 2025, Medtronic plc, an Ireland-based medical technology company, launched the Aurora EV-ICD MRI device and Epsila EV MRI Lead in Japan for the treatment of life-threatening ventricular arrhythmias. The system incorporates an innovative lead placement beneath the sternum, allowing extravascular implantation while delivering antitachycardia pacing (ATP), temporary backup pacing for bradycardia, and up to 40 joules of defibrillation energy. It also provides MRI compatibility, an estimated battery life of 11.7 years, and proprietary sensing algorithms designed to minimize inappropriate shocks. This innovation highlights the increasing focus on less invasive defibrillation technologies that integrate advanced therapeutic capabilities with enhanced patient safety and improved long-term clinical outcomes.

In April 2023, Nordic Capital, a Sweden-based private equity investment firm, acquired a majority stake in Corpuls GmbH for an undisclosed amount. Through this acquisition, Nordic Capital sought to support Corpuls GmbH's global expansion, accelerate innovation in emergency medical technology, and strengthen its position in the external defibrillator and patient monitoring industry. Corpuls GmbH is a Germany-based medical technology company specializing in the development and supply of portable defibrillators.

Major companies operating in the defibrillators market are Abbott Laboratories, Medtronic plc, Stryker Corporation, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Boston Scientific Corporation, ZOLL Medical Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Biotronik SE & Co. KG, Nihon Kohden Corporation, MicroPort Scientific Corporation, Schiller AG, EDAN Instruments Inc., Comen Medical Instruments Co. Ltd., Biolight Meditech Co. Ltd., Shenzhen Biocare Bio-Medical Equipment Co. Ltd., Bexen Cardio S.L., AMI Italia S.p.A., Yuwell Medical Co. Ltd.

North America was the dominating region in the defibrillators market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the defibrillators market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the defibrillators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The defibrillators market consists of sales of manual defibrillators, advanced life support defibrillators, biphasic defibrillators, monophasic defibrillators, cardiac monitoring and defibrillation systems, defibrillator electrodes, paddles, batteries, cables, charging units, data management modules, and other defibrillator-related products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Defibrillators Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses defibrillators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for defibrillators ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The defibrillators market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Implantable Cardioverter Defibrillators; External Defibrillators; Wearable Cardioverter Defibrillators; Automated External Defibrillators
• 2) By Technology: Biphasic Waveform Technology; Monophasic Waveform Technology; Connected Or Smart Internet Of Things Systems
• 3) By Distribution Channel: Direct Sales; Retail And Electronic Commerce
• 4) By Application: Ventricular Tachycardia And Ventricular Fibrillation; Sudden Cardiac Arrest; Cardiac Resynchronization Therapy; Atrial Fibrillation; Bradycardia
• 5) By End User: Hospitals And Clinics; Pre Hospital Emergency Care; Public Access Market; Home Care Settings; Alternative Care Settings; Pre Hospital Care Systems
• Subsegments:
• 1) By Implantable Cardioverter Defibrillators: Transvenous Implantable Cardioverter Defibrillators; Subcutaneous Implantable Cardioverter Defibrillators; Single Chamber Implantable Cardioverter Defibrillators; Dual Chamber Implantable Cardioverter Defibrillators
• 2) By External Defibrillators: Manual External Defibrillators; Manual Automated External Defibrillators; Biphasic External Defibrillators
• 3) By Wearable Cardioverter Defibrillators: Wearable Cardioverter Defibrillator Vests; Wearable Cardiac Monitoring Defibrillator Systems; Portable Wearable Defibrillation Devices
• 4) By Automated External Defibrillators: Semi Automated External Defibrillators; Fully Automated External Defibrillators; Public Access Automated External Defibrillators; Professional Use Automated External Defibrillators
• Companies Mentioned: Abbott Laboratories; Medtronic plc; Stryker Corporation; GE HealthCare Technologies Inc.; Koninklijke Philips N.V.; Boston Scientific Corporation; ZOLL Medical Corporation; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Biotronik SE & Co. KG; Nihon Kohden Corporation; MicroPort Scientific Corporation; Schiller AG; EDAN Instruments Inc.; Comen Medical Instruments Co. Ltd.; Biolight Meditech Co. Ltd.; Shenzhen Biocare Bio-Medical Equipment Co. Ltd.; Bexen Cardio S.L.; AMI Italia S.p.A.; Yuwell Medical Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.